Advanced Biomed Inc. (ADVB)

CIK 0001941029 · Healthcare · Diagnostics and Research

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q3-2026 —
Q2-2026 —
Q1-2026 —
Latest FY-2025 —
Q3-2025 —
Q2-2025 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Audit Information
—
Statements
Unaudited Interim Condensed Consolidated Balance Sheets
—
Consolidated Balance Sheets
—
Unaudited Interim Condensed Consolidated Balance Sheets (P)
—
Consolidated Balance Sheets (P)
—
Unaudited Interim Condensed Consolidated Statements of Operations and Comprehensive Income (loss)
—
Unaudited Interim Condensed Consolidated Statements of Operations and Comprehensive Loss
—
Consolidated Statements of Operations and Comprehensive Loss
—
Unaudited Interim Condensed Consolidated Statements of Changes In Stockholders Equity
—
Consolidated Statements of Changes In Stockholders Equity
—
Unaudited Inteirm Condensed Consolidated Statements of Cash Flows
—
Unaudited Interim Condensed Consolidated Statements of Cash Flows
—
Consolidated Statements of Cash Flows
—
Notes
Accounts Payable, Accruals and Other Current Liabilities
—
Accounts Payable, Accruals and Other Current Liabilities and Amount Due To Related Parties Non-current
—
Accounts Payable, Accruals and Other Current Liabilities and Amount Due To Related Parties Related Corporarions, Non-current
—
Commitments and Contingencies
Concentrations and Risks
Cybersecurity Risk Management and Strategy Disclosure
—
Discontinued Operations and Deconsolidation
—
Equipment, Net
Equity
Income Taxes
Insider Trading Arrangements
Intangible Assets, Net
Liquidity and Going Concern
Organization and Principal Activities
Other Expense, Net
Other Income (expense), Net
—
Other Income, Net
—
Pay Vs Performance Disclosure
Prepaid Expenses and Other Current Assets, Net
Related Party Transactions
Segment Information
Stock Option
Subsequent Events
Summary of Significant Accounting Policies